Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Why don’t more UK radiologists help with suspected physical abuse cases?

Radiologists can make a significant contribution to society by acting as expert witnesses in suspected physical abuse (SBA) cases, according to a new position statement from the British Society of Pediatric Radiology (BSPR). However, certain factors do make providing such a service challenging.

Thumbnail

42% of drug spending comes from private plans

Together, private health insurance, Medicare and Medicaid accounted for 82% of total prescription drug spending in the U.S. in 2017, according to a recent analysis from the Kaiser Family Foundation that broke down drug spending that year.

Thumbnail

Nestlé to sell skin health business for $10B

Consumer goods giant Nestlé is in talks to sell its skin health business to private equity firm EQT and the Abu Dhabi Investment Authority for $10.1 billion, The Wall Street Journal reported.

Thumbnail

Drive by prescription drugs, national health spending up in 2019

National health spending reached $3.76 trillion in March 2019, a 4.6% jump from the same month in 2018, according to recent data from Altarum, underscoring signs of acceleration during the first quarter of 2019.

Thumbnail

Why ICD-10 codes for head CT exams may need to be updated

The ICD-10 codes associated with head CT examinations do not accurately reflect patient complexity, according to a new study published in Current Problems in Diagnostic Radiology.

Thumbnail

JPMorgan Chase drops $500M on healthcare payment system

JPMorgan Chase has acquired InstaMed, a technology company with a focus in healthcare payments, for a purchase price of more than $500 million.

Thumbnail

CMS expands step therapy, backs off controversial pricing proposal in final rule

CMS finalized a rule that aims to boost transparency of the cost of prescription drugs in Medicare Part D and enable Medicare Advantage plans to negotiate better prices for medicines. Notably, the final version backs off a controversial proposal that would have allowed Medicare Part D plans to exclude certain drugs if prices rise beyond a threshold.

 

Thumbnail

Policy update: Catch up on imaging bills moving through state legislatures

Imaging-related policies are currently moving through numerous state legislatures, and the American College of Radiology (ACR) has provided a thorough update on where those bills stand.